Sickle Cell Disease Trial, Recruiting NCT07188766 Sponsor: Imam Abdulrahman Bin Faisal University Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Sickle Cell Disease Trial, Recruiting

NCT07188766
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are older than 18 years old and have been formally diagnosed with Sickle Cell Disease (SCD)
  • You are currently experiencing a pain crisis (a sudden episode of severe pain caused by SCD, sometimes called a vaso-occlusive crisis)
  • Your pain is rated higher than 5 out of 10 on a pain scale
  • You are willing to take part and sign a consent form agreeing to join the study

Who may not be able to join:

  • You need a specific type of specialised fluid management through a drip, as decided by your treating doctor
  • You have congestive heart failure or any form of heart failure affecting how well your heart pumps
  • You have severe long-term kidney failure and are currently receiving dialysis
  • You are showing signs of shock, such as very low blood pressure or signs that your body is not getting enough blood flow
  • You are pregnant or there is a possibility you could be pregnant
  • You have already taken part in this same trial within the past 30 days
  • You are currently enrolled in another research study that involves managing your fluid intake
  • A drip (IV line) cannot be successfully inserted into your vein

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mohammed S Alshahrani, MD, King Fahd Hospital of the University- Imam Abdulrahman Bin Faisal University

Phone: +966556966663

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Imam Abdulrahman Bin Faisal University
Registry
ClinicalTrials.gov
Start date
5 October 2025
Est. completion
1 August 2028

Where this trial is recruiting

🇸🇦 Saudi Arabia

Primary endpoints

Change in Pain intensity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov